NeuroQuest (Canada) Overview

  • Founded
  • 2009
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

NeuroQuest (Canada) General Information

Description

Operator of a drug development company intended o develop drugs for neuropathic pain. The company's drugs focuses on a small molecule drug discovery platform which is based on bioactives discovered in plant extracts showing efficacy for neuropathic pain, which isolates and elucidates medicinal agents from plants and then designs new synthetic drug compounds based on those plant-derived agents, enabling patients to treat neurological conditions.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • 1411 Oxford Street
  • Halifax, Nova Scotia B3H 3Z1
  • Canada
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NeuroQuest (Canada) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 31-Jul-2012 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view NeuroQuest (Canada)’s complete valuation and funding history, request access »

NeuroQuest (Canada) Patents

NeuroQuest (Canada) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20140357725-A1 Terpene analogues and uses thereof for treating neurological conditions Abandoned 14-Jul-2011 0000000000 0
CA-2841972-A1 Terpene analogues and uses thereof for treating neurological conditions Withdrawn 14-Jul-2011 0000000000
CA-2878259-A1 Terpene analogues and uses thereof for treating neurological conditions Abandoned 14-Jul-2011 0000000000
EP-2731924-A1 Terpene analogues and uses thereof for treating neurological conditions Withdrawn 14-Jul-2011 0000000000 0
EP-2731924-A4 Terpene analogues and uses thereof for treating neurological conditions Withdrawn 14-Jul-2011 C07C43/176 0

NeuroQuest (Canada) Executive Team (2)

Name Title Board Seat Contact Info
Robert Cervelli President & Chief Executive Officer
You’re viewing 1 of 2 executive team members. Get the full list »

NeuroQuest (Canada) Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BioNova Accelerator/Incubator Minority 000 0000 000000 0
Emergence Incubator Accelerator/Incubator Minority 000 0000 000000 0
To view NeuroQuest (Canada)’s complete investors history, request access »